DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea
· Delayed Price · Currency is KRW 10,810
-350 (-3.14%)
Feb 21, 2025, 9:00 AM KST
DAE HWA Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
| Market Capitalization | 189,355 | 222,772 | 350,150 | 437,688 | 412,294 | 656,846 | Upgrade
|
| Market Cap Growth | -57.67% | -36.38% | -20.00% | 6.16% | -37.23% | 427.66% | Upgrade
|
| Enterprise Value | 197,042 | 271,655 | 388,012 | 484,753 | 463,521 | 683,200 | Upgrade
|
| Last Close Price | 10810.00 | 11892.72 | 18192.02 | 22569.51 | 21156.62 | 33585.37 | Upgrade
|
| PE Ratio | 17.50 | 21.13 | 52.67 | 34.59 | 110.55 | 167.95 | Upgrade
|
| PS Ratio | 1.63 | 1.94 | 3.18 | 3.58 | 2.90 | 4.72 | Upgrade
|
| PB Ratio | 2.35 | 2.65 | 4.21 | 5.24 | 5.62 | 10.64 | Upgrade
|
| P/TBV Ratio | 2.51 | 3.60 | 5.88 | 6.98 | 7.09 | 12.31 | Upgrade
|
| P/FCF Ratio | - | - | 61.69 | 118.84 | 86.66 | - | Upgrade
|
| P/OCF Ratio | - | - | 33.38 | 40.00 | 46.91 | 270.23 | Upgrade
|
| EV/Sales Ratio | 1.71 | 2.37 | 3.52 | 3.97 | 3.26 | 4.91 | Upgrade
|
| EV/EBITDA Ratio | 16.79 | 23.86 | 40.38 | 39.39 | 49.94 | 74.59 | Upgrade
|
| EV/EBIT Ratio | 33.20 | 47.47 | 75.62 | 59.72 | 85.77 | 122.21 | Upgrade
|
| EV/FCF Ratio | - | - | 68.36 | 131.62 | 97.43 | - | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.61 | 0.54 | 0.59 | 0.68 | 0.54 | Upgrade
|
| Debt / EBITDA Ratio | 4.44 | 4.53 | 4.68 | 4.00 | 5.34 | 3.67 | Upgrade
|
| Debt / FCF Ratio | - | - | 7.92 | 13.37 | 10.42 | - | Upgrade
|
| Asset Turnover | 0.66 | 0.70 | 0.67 | 0.77 | 1.02 | 1.12 | Upgrade
|
| Inventory Turnover | 3.99 | 4.19 | 4.63 | 4.74 | 4.96 | 4.86 | Upgrade
|
| Quick Ratio | 0.39 | 0.45 | 0.56 | 0.59 | 0.65 | 0.68 | Upgrade
|
| Current Ratio | 0.68 | 0.70 | 0.82 | 0.81 | 0.95 | 1.16 | Upgrade
|
| Return on Equity (ROE) | 11.26% | 10.85% | 7.62% | 15.44% | 5.56% | 6.84% | Upgrade
|
| Return on Assets (ROA) | 2.12% | 2.18% | 1.96% | 3.18% | 2.43% | 2.81% | Upgrade
|
| Return on Capital (ROIC) | 2.64% | 2.71% | 2.46% | 3.97% | 3.09% | 3.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.24% | 5.99% | 5.13% | 8.35% | 6.12% | 7.30% | Upgrade
|
| Earnings Yield | 5.68% | 4.73% | 1.90% | 2.89% | 0.90% | 0.60% | Upgrade
|
| FCF Yield | -7.16% | -5.63% | 1.62% | 0.84% | 1.15% | -0.21% | Upgrade
|
| Dividend Yield | 1.39% | 1.26% | 0.82% | - | - | - | Upgrade
|
| Payout Ratio | 8.22% | 25.16% | 39.90% | 13.95% | 47.35% | 45.15% | Upgrade
|
| Buyback Yield / Dilution | -3.43% | -3.42% | -0.06% | 0.01% | 0.12% | -4.07% | Upgrade
|
| Total Shareholder Return | -2.04% | -2.16% | 0.77% | 0.01% | 0.12% | -4.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.